Trials / Completed
CompletedNCT01103544
JAVLOR® Online Non-Interventional Trial
Usage of Vinflunine i.v. (JAVLOR®) for the Treatment of Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium in Adult Patients After Failure of a Cisplatinum-containing Therapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Pierre Fabre Pharma GmbH · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Documentation of data concerning tolerability and efficacy of the intravenous treatment with vinflunine performed under daily routine conditions in Germany. The trial focusses on tolerability including the assessment of the usage of anti-emetic and anti-obstipative concomitant treatment as well as on the efficacy of the treatment.
Conditions
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2011-09-01
- Completion
- 2013-08-01
- First posted
- 2010-04-14
- Last updated
- 2015-05-13
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01103544. Inclusion in this directory is not an endorsement.